The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125313061 12531306 1 I 20160609 20160706 20160706 PER US-SHIRE-US201607186 SHIRE 0.00 M Y 0.00000 20160706 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125313061 12531306 1 PS VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 Oral 20 MG, 1X/DAY:QD (SPRINKLES CONTENTS OF CAPSULE INTO SOMETHING 21977 20 MG CAPSULE QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125313061 12531306 1 Attention deficit/hyperactivity disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125313061 12531306 Dysphagia
125313061 12531306 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found